All About Parsley + 8 Green Sauces To Use It In
Parsley is so much more than a garnish!
FEATURED BROADCASTS
KWN TRENDING
Eat These Foods Today, Look (And Feel) Amazing Tomorrow
Believe it or not, these healthy foods have long and short-term benefits.
Ultrasound Study Reveals How Some Fetuses React to Smoking Moms
Smoking has long been known to cause complications in pregnancy but a new study aims to show how a fetus, of a smoking mother, reacts differently.
U.S. House Republicans face test of unity in budget votes
By David Lawder WASHINGTON (Reuters) – In a test of party unity, Republicans in the U.S. House of Representatives on Wednesday are set to vote on the federal budget, using an unusual format meant to overcome lingering internal disagreements over defense spending. Known as a “Queen of the Hill” vote, the process will let lawmakers vote on several budget alternatives. The idea is to minimize the chances of not passing
Obama says he's ready to sign Medicare doctor payment fix
WASHINGTON (AP) — President Barack Obama says he’s ready to sign good bipartisan legislation to fix Medicare’s doctor payment problem, without endorsing any specific legislation.
A look at some key statistics on rare diseases in the US
The global pharmaceutical industry is make huge investments in treatments for rare diseases, which once drew little interest from major drugmakers. A look at some key statistics on rare diseases:
FDA again expands usage of Regeneron eye drug Eylea
(Reuters) – U.S. health regulators on Wednesday approved Regeneron Pharmaceuticals Inc’s big-selling eye drug Eylea to treat diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in adults. The Food and Drug Administration decision marked the fourth approval for Eylea, an injectable medicine sold in partnership with French drugmaker Sanofi. “Today’s approval gives patients with diabetic retinopathy and diabetic macular edema another therapy to treat
Science, patients driving rare disease drug research surge
TRENTON, N.J. (AP) — The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits.
U.S. consumer safety regulators probes Lumber Liquidators laminates
WASHINGTON (Reuters) – The U.S. Consumer Product Safety Commission said on Wednesday it was investigating laminates used by Lumber Liquidators Holdings Inc, after reports that its products contained too-high levels of formaldehyde. Commission Chairman Elliot Kaye said the regulator would determine in the coming months whether the products were harmful to human health. He said the company had been cooperative so far with the agency’s probe. (Reporting by Emily Stephenson;
Obamacare's Impact on Latino Access to Health Insurance
by Gabriel R. Sanchez, Francisco I. Pedraza and Edward D. Vargas As President Obama’s signature domestic policy achievement, the Affordable Care Act (ACA) faces another test in the upcoming Supreme Court case King v. Burwell. As we await a decision that has huge implications for Obamacare, we take a closer look at whether the ACA has been…
